Related Experiment Videos
[Eosinophil cationic protein in patients with bronchial asthma]
1Department of Medicine and Clinical Immunology, Dokkyo University School of Medicine.
Arerugi = [Allergy]
|February 1, 1991
Summary
Serum eosinophil cationic protein (ECP) levels were higher in asthma patients, correlating with blood eosinophil counts. However, ECP levels did not directly indicate eosinophil activation during asthma attacks.
Area of Science:
- Immunology
- Respiratory Medicine
- Biochemistry
Context:
- Bronchial asthma is a chronic inflammatory airway disease characterized by eosinophilic infiltration.
- Eosinophil cationic protein (ECP) is a key granule protein released by activated eosinophils.
- Understanding the role of eosinophils and their products is crucial for asthma pathogenesis.
Purpose:
- To investigate the relationship between serum eosinophil cationic protein (ECP) levels and bronchial asthma.
- To assess whether serum ECP levels serve as a direct indicator of eosinophil activation in asthma.
Summary:
- Serum ECP levels and blood eosinophil counts were significantly elevated in asthmatic patients compared to non-asthmatic individuals.
- A positive correlation was found between serum ECP levels and blood eosinophil counts in asthma patients.
- During asthma attacks, while blood eosinophil counts increased, serum ECP levels did not significantly differ, suggesting potential enhanced ECP clearance.
Impact:
- Serum ECP levels may not be a precise marker for real-time eosinophil activation or degranulation in asthma.
- Further research is needed to elucidate the complex role of eosinophils and ECP in asthma pathogenesis.
- These findings contribute to a nuanced understanding of asthma biomarkers and inflammatory processes.